Bridgewater Associates, LP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1350694 Westport, CT

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,268,095

+$1,222,495 QoQ

Shares Held

106,592

+24.5% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bridgewater Associates, LP holds $275,081,004 across 28 Biotechnology names. ALNY ranks #2 (12.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	295,579	$48,333,078
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	106,592	$35,268,095
3	HALO	Halozyme Therapeutics, Inc.	511,429	$33,053,656
4	EXEL	Exelixis, Inc.	480,996	$20,629,918
5	BBIO	BridgeBio Pharma, Inc.	259,459	$19,267,425
6	REGN	Regeneron Pharmaceuticals, Inc.	22,724	$17,557,471
7	INCY	Incyte Corp	130,296	$12,263,459
8	KRYS	Krystal Biotech, Inc.	46,367	$11,977,523

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,268,095	106,592	+24.5%	Shares	Sole	2026-05-15
2025-12-31	$34,045,600	85,617	+152.5%	Shares	Sole	2026-02-13
2025-09-30	$15,463,416	33,911	+425.6%	Shares	Sole	2025-11-13
2024-12-31	$1,518,220	6,452	+222.3%	Shares	Sole	2025-02-13
2024-09-30	$550,610	2,002	+2.6%	Shares	Sole	2024-11-13
2023-12-31	$373,440	1,951	+3.4%	Shares	Sole	2024-02-14
2023-09-30	$334,010	1,886	+5.0%	Shares	Sole	2023-11-13
2023-06-30	$341,132	1,796	+43.1%	Shares	Sole	2023-08-11
2023-03-31	$251,401	1,255	-2.2%	Shares	Sole	2023-05-12
2022-09-30	$256,805	1,283	-15.1%	Shares	Sole	2022-11-10
2022-06-30	$220,525	1,512	-32.3%	Shares	Sole	2022-08-11
2021-09-30	$421,801	2,234	-63.4%	Shares	Sole	2021-11-12
2021-06-30	$1,033,902	6,099	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.